Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barre syndrome?

Acta Neurologica Scandinavica

Volumn 102, Issue 2, 2000, Pages 132-134

  Yuki, Nobuhiro ^a   Koga, M ^a   Hirata, K ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Campylobacter jejuni; GD3; Guillain Barre syndrome; Lipopolysaccharide; Miller Fisher syndrome

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; EPITOPE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD3;

ARTICLE; BACTERIAL INFECTION; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; DIARRHEA; ENTERITIS; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; SEROLOGY; SUBCLAVIAN STEAL SYNDROME;

ACUTE DISEASE; ANTIBODIES, BACTERIAL; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CASE-CONTROL STUDIES; DIARRHEA; EPITOPES; FEMALE; GANGLIOSIDES; GASTROENTERITIS; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDES; MALE; MILLER FISHER SYNDROME;

EID: 0033943325     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2000.102002132.x     Document Type: Article

References (14)

1. 1. REES JH, SOUDAIN SE, GREGSON NA, HUGHES RAC. Campylobacter jejuni infection and Guillain Barré syndrome. N Engl J Med 1995;333:1374-9.
2. 2. KOGA M, YUKI N, TAKAHASHI M, SAITO K, HIRATA K. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain Barré and Fisher's syndromes. J Neuroimmunol 1998;81:138-43.
3. 3. YUKI N, TSUJINO Y. Familial Guillain Barré syndrome subsequent to Campylobacter jejuni enteritis. J Pediatr 1995;126: 162.
4. 4. ASPINALL GO, MCDONALD AG, PANG H. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of O antigen chains from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry 1994;33:250-5.
5. 5. SALLOWAY S, MERMEL LA, SEAMANS M et al. Miller-Fisher [sic] syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3. Infect Immun 1996;64:2945-9.
6. 6. PENNER JL, ASPINALL GO. Diversity of lipopolysaccharide structures in Campylobacter jejuni. J Infect Dis 1997;176 (Suppl):S135-8.
7. 7. THORNTON CA, GRIGGS RC. Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease. Ann Neurol 1994;35:260-8.
8. 8. ASBURY AK, CORNBLATH DR. Assessment of current diagnostic criteria for Guillain Barré syndrome. Ann Neurol 1990;27(Suppl):S21-4.
9. 9. ROPPER AH, WIJDICKS EFM, TRUAX BT. Guillain Barré Syndrome. Philadelphia: F.A. Davis 1991:18-21.
10. 10. YUKI N, TAKI T, HANDA S. Antibody to Ga1NAc-GD1a and Ga1NAc-GM1b in Guillain Barré syndrome subsequent to Campylobacter jejuni enteritis. J Neuroimmunol 1996;71: 155-61.
11. 11. OGAWA-GOTO K, FUNAMOTO N, ABE T, NAGASHIMA N. Different ceramide compositions of gangliosides between human motor and sensory nerves. J Neurochem 1990;55:1486-93.
12. 12. CHIBA A, KUSUNOKI S, OBATA H, MACHINAMI R, KANAZAWA I. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res 1997;745:32-6.
13. 13. YUKI N, HANDA S, TAI T et al. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain Barré syndrome. J Neurol Sci 1995;130:112-16.
14. 14. NAM SHIN JE, ACKLOO S, MAINKAR AS et al. Lipo-oligosaccharides of Campylobacter jejuni serotype O:10: structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher [sic] syndrome and from the serotype reference strain. Carbohydr Res 1998;305:223-32.